Advertisement
Advertisement
Tri-Plus

Tri-Plus

trimetazidine

Manufacturer:

Pell Tech Healthcare

Distributor:

Corbridge
Concise Prescribing Info
Contents
Trimetazidine HCl
Indications/Uses
Add-on therapy for symptomatic treatment of adults w/ stable angina pectoris who are inadequately controlled by or intolerant to 1st-line anti-anginal therapies.
Dosage/Direction for Use
Administration
Should be taken with food.
Contraindications
Hypersensitivity. Parkinson's disease, parkinsonian symptoms, tremors, restless leg syndrome, & other related movement disorders. Severe renal impairment (CrCl <30 mL/min).
Special Precautions
Discontinue use in occurrence of movement disorders eg, parkinsonian symptoms, restless leg syndrome, tremors, gait instability. Not a curative treatment for angina attacks nor an initial treatment for unstable angina, or MI. Not to be used in the pre-hospital phase nor during the 1st days of hospitalization. Can cause or worsen parkinsonian symptoms (tremor, akinesia, hypertonia). Reevaluate angina pectoris in the event of angina attack. Falls may occur. Safety & efficacy have not been established in childn <18 yr. Increased exposure in the elderly.
Adverse Reactions
Dizziness, headache; abdominal pain, diarrhea, dyspepsia, nausea & vomiting; rash, pruritus, urticaria; asthenia.
MIMS Class
Anti-Anginal Drugs
ATC Classification
C01EB15 - trimetazidine ; Belongs to the class of other cardiac preparations.
Presentation/Packing
Form
Tri-Plus SR cap 60 mg
Packing/Price
30's
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement